
Rapamycin did not slow atherosclerosis in marmosets, and why stents use it anyway
Louis cites Adam Salmon's marmoset work showing rapamycin had no clear effect on aging cardiovascular function, with plaque developing at the same rate as controls. He considers it unwise to rely on rapamycin to prevent heart disease. He also explains rapamycin on stents works by blocking scar tissue (neointimal hyperplasia), not plaque growth.